Texto Cientifico

Áñez, G., et al. Safety and immunogenicity of four sequential doses of NVX-CoV2373 in adults and adolescents: A phase 3, randomized, placebo-controlled trial (PREVENT-19). Vaccine, 2025 Jun 5, [...]

Zhaoyun, L., et al. Enhancing antitumor immunity via ROS-ERS and pyroptosis-induced immunogenic cell death in multiple myeloma. J Immunother Cancer, 2025 Jun 4, 13(6):e011717. PMID: 40473272 The [...]

Eygeris, Y., et al. Exploring the potential of saponins as adjuvants in lipid-nanoparticle-based mRNA vaccines. Mol Ther Methods Clin Dev, 2025 May 21, 33(2):101495. PMID: 40525124 This study [...]

Rodrigues, K.A., et al. Vaccines combining slow release and follicle targeting of antigens increase germinal center B cell diversity and clonal expansion. Sci Transl Med, 2025 Jun 18, [...]

Taquet, M., et al. Lower risk of dementia with AS01-adjuvanted vaccination against shingles and respiratory syncytial virus infections. NPJ Vaccines, 2025 Jun 25, 10(1):130. PMID: 40562756 The [...]

Hayek, H., et al. Vaccine Adjuvants in the Immunocompromised Host: Science, Safety, and Efficacy. Transpl Infect Dis, 2025 May 19, e70053. PMID: 40387162 This comprehensive review discusses the [...]

Hu, J., et al. Herpes simplex virus 1 fusion glycoprotein B H516P prefusion mutation had no effect on vaccine immunogenicity. Vaccine, 2025 May 31, 57:127241. PMID: 40354699 This study [...]

Shi, P., et al. Discovery of novel adjuvants: Identification of saponins from Hylomecon japonica (Thunb.) Prantl & Kündig and insights into their in vitro and in vivo activities. Bioorg Chem, [...]

Lu, X., et al. Natural products targeting tumour angiogenesis. Br J Pharmacol, 2025 May, 182(10):2094-2136. PMID: 37680009 This comprehensive review highlights the potential of natural products [...]

Alves, K., et al. Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein vaccine as a heterologous booster dose in US adults: interim analysis of a [...]